3[7]Nakabayashi M,Oh WK. Neoadjuvant and adjuvant chemoth-erapy for high-risk localized prostate cancer[J]. Curr Treat Options Oncol,2004,5(5):349
4[8]Schmoll HJ,Souchon R,Krege S,et al.European consensus on diagnosis and treatment of germ cell cancer:a report of the European germ cell cancer consensus group(EGCCCG)[J]. Ann Oncol,2004,15(9):1377
5[9]Urata H,Hori H,Uchida k,et al.Strategy for the treatment of unresectable hepatoblastoma:neoadjuvant chemotherapy followed by delayed primary operation or liver transplantation[J]. Int Surg,2004,89(2):95
6[10]Psyrri A,Kwong M,Distasio S,et al. Cisplatin,fluorouracil,and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer:long-term follow-up[J]. J Clin Oncol,2004,22(15):3061
7[11]Offidani M,Corvatta L,Malerba L,et al. Risk assenssment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates:a historical cohort study[J]. Cancer,2004,101(3):567
8[12]Kesler KA,Wright CD,Loehrer PJ Sr.Thymoma:current medical and surgical management[J]. Semin Neurol,2004,24(1):63
9[13]Westphal M,Hilt DC,Bortey E,et al. A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers in patients with primary malignant glioma[J]. Neuro-oncol,2003,5(2):79
10[14]Coriazar P,Johnson BE. Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer[J]. Journal of Clinical Oncology,1999,17(5):1625
2J.K wilson,J.M.Sargent,A.W.Elgie,et al,A feasibility.study of the MTT assay for chemosensitivity testing in ovarian malignancy. British Journal of Cancer . 1990
3Toshibaru Furakawa MD,Testuto Kubota MD,Akihiko Suto MD et al.Clinical usefulness.of chemosensitivity testing using the MTT assay. Journal of Surgery . 1992
4R.Pieters,D.R.Huismans,A.Leyva,et al.Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensityvity testing in child hood leukaomia. British Journal of Cancer . 1989
5Yoshiro Saikawa.Tesuro Kubota,Toshihara Furukawa,et al.Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. Japanese Journal of Cancer Research . 1994
6H.Yamaue,H,Tanimura,K.Noguchi,et al.Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. British Journal of Cancer . 1992
7Teruaki Hongo,MD.YujiFuji and Yoshio lgarashi.MD.An in vitro chemosensitivity test for the screening of an-ti-cancer drugs in childhood leukemia. Cancer . 1990
8R.Abe,H.Ueo,T.Akiyoshi.Evaluation of MTT assay in agarose for chemosensitivity testing of human cancers comparison with MTT assay. Oncology . 1994
9Tadashi Nakashima,Tukuya Vemura,Yoshihiko Maehara,et al.Succinate Dehydrogenase Inhibition Test for Evaluating Head and Neck Tumors. Oncology . 1989
5Zhao LB, Wang XM, Wu JH, et al. Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics [J].Journal of Chromatography B, 2007, 857 (2): 341-346.
6Klose D, Siepmann F, Elkharraz K, et al. PLGA-based drug delivery systems: Importance of the type of drug and device ge- ometry[J]. International Journal of Pharmaceutics, 2008, 354 (1 2): 95-103.
7Wang M, Thanou M. Targeting nanoparticles to cancer [J]. Pharmaeological Research, 2010, 62 (2): 90-99.
8Murakami H, Kobayashi M, Takeuchi, et al. Further ap- plication of a modified spontaneous emulsification solvent diffu sion method to various types of PLGA and PLA polymers for preparation of nanoparticles EJ~- Powder Tech, 2000, 107 (1-2) : 137-143.
9Holgado MA, Arias JL, Cozar MJ, et al. Synthesis of lido- caine-loaded PLGA microparticles by flow focusing Effects on drug loading and release properties [J]. International Journal of Pharmaceutics, 2008, 358 (1-2)2 27-35.
10Song XR, Zhao Y, Hou SX, et al. Dual agents loaded PLGA nanopartieles.. Systematic study of particle size and drug en- trapment efficiency [J]. European Joumal of Pharmaceutics and Biopharmaceutics, 2008, 69 (2): 445-453.
